Cargando…
Infectious complications during monoclonal antibodies treatments and cell therapies in Acute Lymphoblastic Leukemia
Infections represent one of the most frequent complications during the treatment of patients with Acute Lymphoblastic Leukemia (ALL): of these, almost half develop an infectious event in the majority of cases in induction. The new monoclonal and bispecific antibodies and CAR-T, besides offering new...
Autores principales: | Quattrone, Martina, Di Pilla, Alessia, Pagano, Livio, Fianchi, Luana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885910/ https://www.ncbi.nlm.nih.gov/pubmed/36715833 http://dx.doi.org/10.1007/s10238-023-01000-9 |
Ejemplares similares
-
Disseminated Geosmithia argillacea Infection in a Patient with Ph-Positive Acute Lymphoblastic Leukemia. Case Report and Literature Review
por: Giordano, Antonio, et al.
Publicado: (2021) -
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
por: Abuasab, Tareq, et al.
Publicado: (2021) -
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years’ Experience
por: Fianchi, Luana, et al.
Publicado: (2021) -
Incidence of Acute Myeloid Leukemia after Breast Cancer
por: Valentini, Caterina Giovanna, et al.
Publicado: (2011) -
Similarities and Differences Between Therapy-Related and Elderly Acute Myeloid Leukemia
por: D’Alò, Francesco, et al.
Publicado: (2011)